Firm profile

PHARMAKON ADVISORS, LP

NEW YORK, NYCRD 161150Latest ADV March 31, 2026

Pharmakon Advisors, LP is an SEC registered investment adviser organized as a limited partnership with a primary office location in New York, NY. Its latest Form ADV filing, dated March 31, 2026, reports $3.0B in regulatory assets under management, 15 employees, and 5 accounts.

Assets Under Management
$3.0B
Employees
15
Offices
--
Total Clients
5
Primary office
NEW YORK, NY
110 EAST 59TH STREET, 28TH FLOOR, NEW YORK, NY, United States
ADV Item 1F location record

Contact and digital presence

ADV profile links

Leadership

2 roles identified
CEOPedro N. Gonzalez De Cosio
CCODouglas Y. Kim

Advisory services offered

2 types reported
Other advisory services
Portfolio management for pooled investment vehicles

Fee models offered

2 types reported
Asset based fees
Performance-based fees
Sources checked May 16, 2026

Client Coverage Demographics

Top client segmentPooled Investment Vehicles represent 80.0% of total clients.
Top client categories% of clientsClients
1
Pooled Investment Vehicles
80.0%
4
2
Irrevocable Trusts/Estates
20.0%
1

Regulatory Assets Under Management Breakdown

Total regulatory assets under management$3.0Bas of March 31, 2026
Discretionary100.0%
$3.0B
100% of total RAUM100.0%
Non-discretionary0.0%
$0
0% of total RAUM0.0%
All regulatory assets under management are discretionary.

Assets under management Growth by Quarter

Quarterly points use the latest ADV filing or SEC roster snapshot available in each quarter.

Total AUM$3.0B
Total Accounts5
10Y AUM Change+$2.1B (+231.9%)

Employee Growth by Quarter

Quarterly points use the latest ADV filing or SEC roster snapshot available in each quarter.

Total Employees15
Clients per Employee0:1
10Y Employee Change+10 (+200.0%)

* Metrics are based on the latest available data, including Form ADV filings, brochures, and relationship summaries pulled from the SEC IAPD, and may be subject to change. Learn what is included in the Rialytix data. Please refer to the firm's official disclosures for the most accurate information using their CRD number. This is not investment advice.